Article Details

China's HLC, Panacea lead $100m funding in biotech startup Inmagene

Retrieved on: 2021-06-01 04:41:15

Tags for this article:

Click the tags to see associated articles and topics

China's HLC, Panacea lead $100m funding in biotech startup Inmagene. View article details on hiswai:

Excerpt

The new round attracted capital injections from new investors, such as VMS Asset Management, an investment arm of Hong Kong-based financial firm ...

Article found on: www.dealstreetasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up